Among them, EETs and 11-HETE were the most interesting, with EETs being a vital factor for tumour angiogenesis and 11-HETE being the only increased eicosanoid in all PPARα agonist-treated groups and tissues. The gene discussed is PPARA; the disease is neoplasm.